biOasis Technologies (OTCMKTS:BIOAF) and Herbalife Nutrition (NYSE:HLF) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Risk & Volatility

biOasis Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Herbalife Nutrition has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for biOasis Technologies and Herbalife Nutrition, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
biOasis Technologies 0 0 0 0 N/A
Herbalife Nutrition 0 3 5 0 2.63

Herbalife Nutrition has a consensus target price of $58.70, suggesting a potential upside of 6.69%. Given Herbalife Nutrition’s higher probable upside, analysts plainly believe Herbalife Nutrition is more favorable than biOasis Technologies.

Earnings & Valuation

This table compares biOasis Technologies and Herbalife Nutrition’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
biOasis Technologies $460,000.00 32.57 -$4.12 million N/A N/A
Herbalife Nutrition $4.43 billion 1.94 $213.90 million $2.43 22.64

Herbalife Nutrition has higher revenue and earnings than biOasis Technologies.

Insider & Institutional Ownership

91.3% of Herbalife Nutrition shares are held by institutional investors. 6.2% of Herbalife Nutrition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares biOasis Technologies and Herbalife Nutrition’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
biOasis Technologies -1,517.77% -407.59% -264.48%
Herbalife Nutrition 3.84% -82.17% 15.61%


Herbalife Nutrition beats biOasis Technologies on 10 of the 11 factors compared between the two stocks.

About biOasis Technologies

biOasis Technologies, Inc. is a biopharmaceutical company focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include Transcend program as its proprietary carrier, p97, and components thereof, to deliver therapeutics and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in Vancouver, Canada.

About Herbalife Nutrition

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products comprising dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products consisting of facial skin, body, and hair care products; and energy, sports, and fitness products, such as N-R-G tea and energy drink products. It also provides literature, promotional, and other materials, including start-up kits, sales tools, and educational materials. The company offers its products through own retail stores, as well as through independent service providers, sales representatives, and sales officers. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Receive News & Ratings for biOasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biOasis Technologies and related companies with's FREE daily email newsletter.